Showing 1 - 10 of 13
A recent study by professors found that women represent only one-third of the top pharmaceutical patent litigators and one-quarter of lawyers who help inventors obtain these valuable pharmaceutical patents. This lack of representation in the pharmaceutical patent field is surprising because...
Persistent link: https://www.econbiz.de/10014359052
Bioprinting is an additive manufacturing process used to create architectures that mimic natural living tissues in form and function. It involves the deposition of bioink, which can include a mixture of living cells, nutrients, and extracellular matrix. The bioink is then deposited onto a...
Persistent link: https://www.econbiz.de/10014359053
This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.Link to full text at JAMA: https://jamanetwork.com/journals/jama/fullarticle/2800700
Persistent link: https://www.econbiz.de/10014359054
This paper evaluates the potential impact of the Supreme Court’s upcoming decision on antibody patents and patent law’s enablement requirement on patient access to new drugs.This article was published in JAMA at https://jamanetwork.com/journals/jama/fullarticle/2803076
Persistent link: https://www.econbiz.de/10014346525
Less than a handful of casebooks are truly open source, in the sense of being fully modifiable. Patent Law: An Open-Source Casebook is the first patent law casebook that provides adopting professors, students, and others the ability to fully modify its contents. This file comprises the casebook...
Persistent link: https://www.econbiz.de/10013229551
Less than a handful of casebooks are truly open source, in the sense of being fully modifiable. Patent Law: An Open-Source Casebook is the first patent law casebook that provides adopting professors, students, and others the ability to fully modify its contents. This file includes the cover,...
Persistent link: https://www.econbiz.de/10013230697
Examiner interviews are one of the most powerful tools to help both inventors and examiners understand and overcome specific issues during prosecution. Direct discussions between an applicant and an examiner can help bridge the gap between misunderstandings of prior art, the invention or...
Persistent link: https://www.econbiz.de/10013233691
Pharmaceutical patents listed in the FDA’s “Orange Book” are some of the most valuable patents in the world. Accordingly, for this valuable subset of patents, it is paramount that the Patent & Trademark Office (PTO) correctly issue valid patents and preclude invalid patents from issuing....
Persistent link: https://www.econbiz.de/10013214907
In a set of two studies , I determine: (1) which examiners are sending patents to litigation and, of those, (2) which examiners are sending invalidated patents to litigation. Together, these studies determine what conditions might predict the likelihood of an examiner’s patents getting...
Persistent link: https://www.econbiz.de/10013212049
Antibody patents form the basis of some of the most valuable biotechnology products on the market. In 2020 alone, the sales of the top three drugs exceed 10 billion dollars. Two of those three drugs are monoclonal antibodies (Humira and Keytruda). In the past, patent law offered broad protection...
Persistent link: https://www.econbiz.de/10013294263